Mc r

1 study on Mc r mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

2026-04-03 PubMed · in vitro · n preclinical

KPV tripeptide retains α-MSH anti-inflammatory potency without pigmentary side effects

**KPV and KdPT reframe the anti-inflammatory potential of α-MSH by stripping it down to a receptor-independent, pigmentation-free tripeptide** — a meaningful leap for any clinician or researcher frustrated by full-hor…

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.